Protective immune correlates can segregate by vaccine type in a murine herpes model system

International Immunology

Volumn 11, Issue 11, 1999, Pages 1763-1773

  Sin, Jeong Im ^b   Ayyavoo, Velpandi ^b   Boyer, Jean ^b   Kim, Jong ^b   Ciccarelli, Richard B ^a,b   Weiner, David B ^b  

^a WLV   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DNA vaccine; Herpes simplex virus infection; Protective correlates; Subunit vaccine; T(h)1; T(h)2

Indexed keywords

ANTIGEN; DNA VACCINE; HERPES VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PROLYLLEUCYLGLYCINAMIDE; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; HELPER CELL; HERPES; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LETHAL DOSE; MORBIDITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CHEMOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0032716322     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.11.1763     Document Type: Article

References (59)

1. Nahmias, A. J., Dannenbarger, J., Wickliffe, C. and Muther, J. 1980. Clinical Aspects of Infection with Herpes Simplex Virus 1 and 2. Elsevier, New York.
2. Manservigi, R., Grossi, M. P., Gualandri, R., Balboni, P. G., Marchini, A., Rotola, A., Rimessi, P., DiLuca, D., Cassai, E. and Barbanti-Brodano, G. 1990. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein C constitutively expressed in human cells with a BK virus episomal vector. J. Virol. 64:431.
3. Ghiasi, H., Kaiwar, R., Nesburn, A. and Wechsler, S. 1992. Baculovirus-expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Res. 18:291.
4. Ghiasi, H., Kaiwar, R., Nesburn, A., Slanina, S. and Wechsler, S. 1992. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology 188:469.
5. Ghiasi, H., Kaiwar, R., Nesburn, A. and Wechsler, S. 1992. Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: preliminary biochemical characterization and protection studies. J. Virol. 66:2505.
6. Peng, T., Ponce-de-Leon, M., Jiang, H., Dubin, G., Lubinski, J. M., Eisenberg, R. J. and Cohen, G. H. 1998. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge. J. Virol. 72:65.
7. Long, D., Madara, T. J., de Leon, M. P., Cohen, G. H., Montgomery, P. C. and Eisenberg, R. J. 1984. Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect. Immunity 43:761.
8. Straus, S. E., Wald, A., Kost, R. G., McKenzie, R., Langenberg, A. G., Hohman, P., Lekstrom, J., Cox, E., Nakamura, M., Sekulovich, R., Izu, A., Dekker, C. and Corey, L. 1997. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J. Infect. Dis. 176:1129.
9. Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A., Boyer, J., Williams, W. V. and Weiner, D. B. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 90:4156.
10. Wang, B., Boyer, J. D., Srikantan, V., Coney, L., Carrano, R., Phan, C., Merva, M., Dang, K., Agadjanyan, M. G., Ugen, K. E., Williams, W. V. and Weiner, D. B. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DNA Cell Biol. 12:799.
11. Kuhober, A., Pudollek, H. P., Reifenberg, K., Chisari, F. V., Schlicht, H. J., Reimann, J. and Schirmbeck, R. 1996. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J. Immunol. 156:3687.
12. Lagging, L. M., Meyer, K., Hoft, D., Houghton, M., Belshe, R. B. and Ray, R. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859.
13. Major, M. E., Vitvitski, L., Mink, M., A., Schleef, M., Whalen, R. G., Trepo, C. and Inchauspe, G. 1995. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:5798.
14. Ulmer, J. B., Donnelly, J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. L., Gromkowski, S. H., Deck, R., DeVitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Marinez, D., Perry, H., Shiver, J. W., Montgomery, D. and Liu, M. A. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
15. Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J. and Ertl, H. C. J. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
16. Bourne, N., Stanberry, L. R., Bernstein, D. I. and Lew, D. 1996. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:800.
17. Kriesel, J. D., Spruance, S. L., Daynes, R. A. and Araneo, B. A. 1996. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 173:536.
18. Sin, J. I., Sung, J. H., Sun, Y. S., Lee, A. H., Chung, J. H. and Sung, Y. C. 1997. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of co-injection with a granulocyte, macrophage-colony stimulating factor gene. Vaccine 15:1827.
19. Chen, S. C., Fynan, E. F., Robinson, H. L., Lu, S., Greenberg, H. B., Santoro, J. C. and Herrmann, J. E. 1997. Protective immunity induced by rotavirus DNA vaccine. Vaccine 15:899.
20. Xu, L., Sanchez, A., Yang, Z., Zaki, S. R., Nabel, E. G., Nichol, S. T. and Nabel, G. J. 1998. Immunization for Ebola virus infection. Nat. Med. 4:37.
21. h1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte macrophage-colony stimulating factor expression cassettes. Eur. J. Immunol. 28:3530.
22. Boyer, J. D., Ugen, K. E., Wang, B., Agadjanyan, M., Gilbert, L., Bagarazzi, M. L., Chattergoon, M., Frost, P., Javadian, A., Williams, W. V., Refaeli, Y., Ciccarelli, R. B., McCallus, D., Coney, L. and Weiner, D. B. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526.
23. MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., Coney, L. R., Ginsberg, R. S. and Weiner, D. B. 1998. First clinical trial of a DNA-based vaccine for treatment of HIV-1 infection: safety and host response. J. Infect. Dis. 178:92.
24. Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones, T. R., Hobart, P., Margalith, M., Ng, J., Weiss, W. R., Sedegah, M., de Taisne, C., Norman, J. A. and Hoffman, S. L. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476.
25. + T lymphocytes. J. Immunol. 155:259.
26. Manickan, E., Yu, Z., Rouse, R. J., Wire, W. S. and Rouse, B. T. 1995. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. 8:53.
27. Pachuk, C. J., Arnold, R., Herold, K., Ciccarelli, R. B. and Higgins, T. J. 1998. Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice. Curr. Top. Microbiol. Immunol. 226:79.
28. h1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. J. Virol. 73:501.
29. Oppenheim, J. J., Zachariae, C. O., Mukaida, N. and Matsushima, K. 1991. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu. Rev. Immunol. 9:617.
30. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
31. + T cells. Science 270:1811.
32. Price, R. W., Walz, M. A., Wohlenberg, C. and Notkins, A. L. 1975. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science 188:938.
33. Notkins, A. L. 1974. Immune mechanisms by which the spread of viral infections is stopped. Cell. Immunol. 11:478.
34. Kohl, S., Starr, S. E., Oleske, J. M., Shore, S. L., Ashman, R. B. and Nahmias, A. J. 1977. Human monocyte-macrophage-mediated antibody dependent cytotoxicity to herpes simplex virus-infected cells. J. Immunol. 118:729.
35. Norrild, B., Shore, S. L. and Nahmias, A. J. 1979. Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytosis and their correlation with previously identified glycopolypeptides. J. Virol. 32:741.
36. Sethi, K. K., Omata, Y. and Schneweis, K. E. 1983. Protection of mice from lethal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J. Gen. Virol. 64:443.
37. + T cells produce gamma-interferon in patients with recurrent herpes labialis. J. Immunol. 132:197.
38. + CTL clones recognize HSV-2 infected fibroblasts after treatment with IFN-γamma or when virion host shutoff functions are disabled. J. Immunol. 156:3901.
39. Rager-Zisman, B. and Allison, A. C. 1976. Mechanism of immunologic resistance to herpes simplex virus (HSV-1) infection. J. Immunol. 116:35.
40. Eis-Hubinger, A. M., Schmidt, D. S. and Schneweis, K. E. 1993. Anti-glycoprotein B monoclonal antibody protects T cell depleted mice against herpes simplex virus by inhibition of virus replication at the inoculated mucous membrane. J. Gen. Virol. 74:379.
41. Rosavad, C. M., Koelle, D. M. and Corey, L. 1998. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat. Med. 4:381.
42. Korsager, B., Spencer, S., Mordhurst, C. and Anderson, H. K. 1975. Herpesvirus hominis infections in renal transplant recipients. Scand. J. Infect. Dis. 7:11.
43. Sheridan, J. F., Donnenberg, A. D., Aurelian, L. and Elpern, D. J. 1982. Immunity to herpes simplex virus type 2: IV. impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. J. Immunol. 129:326.
44. Kapoor, A. K., Nash, A. A. and Wildy, P. 1982. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell mediated and humoral immunity. J. Gen. Virol. 61:127.
45. Milligan, G. N. and Bernstein, D. I. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481.
46. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825.
47. Kuklin, N. A., Daheshia, M., Chun, S. and Rouse, B. T. 1998. Role of mucosal immunity in herpes simplex virus infection. J. Immunol. 160:5998.
48. Yu, Z., Manickan, E. and Rouse, B. T. 1996. Role of interferon-gamma in immunity to herpes simplex virus. J. Leuk. Biol. 60:528.
49. + T cell mediated protective immunity against HSV-2 challenge. J. Immunol. 162:2912.
50. h1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl Acad. Sci. USA 93:5141.
51. Kim, J. J., Nottingham, L. K., Sin, J. I., Tsai, A., Morrison, L., Dang, K., Hu, Y., Kazahaya, K., Bennett, M., Dentchev, T., Wilson, D. M., Chalian, A. A., Boyer, J. D., Agadjanyan, M. G. and Weiner, D. B. 1998. CD8 positive T-cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102:1112.
52. h2 responses. Int. J. Clin. Lab. Res. 28:77.
53. Tumpey, T. M., Cheng, H., Yan, X.-T., Oakes, J. E. and Lausch, R. N. 1998. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J. Leuk. Biol. 63:486.
54. Mikloska, A. and Cunningham, A. L. 1998. Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79:353.
55. Ho, M. 1990. Interferon as an agent against herpes simplex virus. J. Invest. Dermatol. 95:158S.
56. Koelle, D. M., Frank, J. M., Johnson, M. L. and Kwok, W. W. 1998. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J. Virol. 72:7476.
57. Minato, N., Reid, L., Cantor, H., Lengyel, P. and Bloom, B. R. 1980. Mode of regulation of natural killer cell activity by interferon. J. Exp. Med. 152:124.
58. Habu, S., Akamatsu, K. I., Tamaoki, N. and Okumura, K. 1984. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133:2743.
59. Smith, P. M., Wolcott, R. M., Chervenak, R. and Jennings, S. R. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology 202:76.